{"schema_version":"1","generated_at":"2026-11-05T05:06:06.147Z","data_as_of":null,"url":"https://www.findmykol.com/kol/jeffrey-smith-ma","json_url":"https://www.findmykol.com/kol/jeffrey-smith-ma/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"jeffrey-smith-ma","name":"Jeffrey Smith","credential":"MD, PhD","specialty":"Dermatology","specialty_raw":"Dermatology","therapeutic_area":"Dermatology","therapeutic_areas":["Dermatology"],"city":"Boston","state":"MA","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1437713344"},"summary":"Jeffrey Smith is a Dermatology physician.","overview":null,"focus":{"indications":[],"research_topics":["Dermatology"]},"scholarship":{"note":"Research metrics are not shown for this record: either no confident publication match for this name, or more than one clinician shares the matched author record."},"payments":{"company_count":6,"program_years":{"first":2021,"last":null},"rows_total":7,"shown":3,"withheld":4,"rows":[{"payer":"Galderma Laboratories, L.P.","program_year":2025,"amount_usd":106.78,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1437713344"},{"payer":"E.R. Squibb & Sons, L.L.C.","program_year":2025,"amount_usd":34.16,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1437713344"},{"payer":"E.R. Squibb & Sons, L.L.C.","program_year":2023,"amount_usd":108.86,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1437713344"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1437713344","source":"payments"},"prescribing":{"data_year":2024,"areas_total":7,"areas_shown":3,"areas":[{"area":"Dermatology","share_pct":32.9,"classes_total":2,"classes":[{"class":"Interleukin-4 Receptor alpha Antagonist","setting":"prescribed","share_pct":28,"drugs":[{"name":"Dupixent Pen","share_pct":83.8},{"name":"Dupixent Syringe","share_pct":16.2}],"max_beneficiaries":null},{"class":"Corticosteroid","setting":"prescribed","share_pct":4.9,"drugs":[{"name":"Triamcinolone Acetonide","share_pct":100}],"max_beneficiaries":null}]},{"area":"Cancer & immunology","share_pct":25.1,"classes_total":3,"classes":[{"class":"Folate Analog Metabolic Inhibitor","setting":"prescribed","share_pct":15.2,"drugs":[{"name":"Methotrexate","share_pct":100}],"max_beneficiaries":null},{"class":"JAK inhibitor","setting":"prescribed","share_pct":4.9,"drugs":[{"name":"Rinvoq","share_pct":100}],"max_beneficiaries":null}]},{"area":"Antiparasitic","share_pct":15.6,"classes_total":1,"classes":[{"class":"Antimalarial","setting":"prescribed","share_pct":15.6,"drugs":[{"name":"Hydroxychloroquine Sulfate","share_pct":71.1},{"name":"Chloroquine Phosphate","share_pct":28.9}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"office","data_year":2024,"office_pct":100,"facility_pct":0},"source":"medicare"},"funding":{"award_count":1,"fiscal_years":{"first":2024,"last":2026},"rows_total":3,"shown":3,"withheld":0,"matched_by":"principal investigator name at an organization in the practice state","rows":[{"project":"K08AR084617","title":"Biochemical Determinants of Chemokine Receptor Signaling","fiscal_year":2026,"amount_usd":"170264","organization":"BRIGHAM AND WOMEN'S HOSPITAL","source_url":"https://reporter.nih.gov/quickSearch/K08AR084617"},{"project":"K08AR084617","title":"Biochemical Determinants of Chemokine Receptor Signaling","fiscal_year":2025,"amount_usd":"168029","organization":"BRIGHAM AND WOMEN'S HOSPITAL","source_url":"https://reporter.nih.gov/quickSearch/K08AR084617"},{"project":"K08AR084617","title":"Biochemical Determinants of Chemokine Receptor Signaling","fiscal_year":2024,"amount_usd":"163514","organization":"BRIGHAM AND WOMEN'S HOSPITAL","source_url":"https://reporter.nih.gov/quickSearch/K08AR084617"}],"source":"grants"},"contact":{"address_1":"221 LONGWOOD AVE","city":"Boston","state":"MA","zip":"021155817","phone":"617-732-4918","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1437713344","source":"identity"},"similar":[{"name":"Robert Modlin","slug":"robert-modlin","institution":"University of California, Los Angeles","specialty":"Dermatology","url":"https://www.findmykol.com/kol/robert-modlin","json_url":"https://www.findmykol.com/kol/robert-modlin/profile.json"},{"name":"Jon Hanifin","slug":"jon-hanifin","institution":"Oregon Health & Science University (OHSU)","specialty":"Dermatology","url":"https://www.findmykol.com/kol/jon-hanifin","json_url":"https://www.findmykol.com/kol/jon-hanifin/profile.json"},{"name":"Heidi Kong","slug":"heidi-kong","institution":"National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)","specialty":"Dermatology","url":"https://www.findmykol.com/kol/heidi-kong","json_url":"https://www.findmykol.com/kol/heidi-kong/profile.json"},{"name":"Joel Gelfand","slug":"joel-gelfand","institution":"University of Pennsylvania","specialty":"Dermatology","url":"https://www.findmykol.com/kol/joel-gelfand","json_url":"https://www.findmykol.com/kol/joel-gelfand/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":4}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2023-08-30","provider_certified":"2023-08-30","collected_at":"2026-11-04T00:00:00.000Z"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}